Mission Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mission Wealth Management's BIIB Position: Q2 2026 in Review
Mission Wealth Management increased its Biogen (BIIB) stake by 47% in Q2 2026, buying an estimated $147K and bringing the position to 2,387 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #676.
Mission Wealth Management first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Mission Wealth Management held 2,387 shares of Biogen worth $516K as of Q2 2026.
- Mission Wealth Management bought 766 Biogen shares in Q2 2026, an estimated $147K.
- Biogen made up 0.01% of Mission Wealth Management's portfolio in Q2 2026, its #676 holding.
- Mission Wealth Management first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.